- STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.STAT · 5d ago↗ source
- Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drugRoyalty Pharma has secured a stake in another transthyretin-mediated amyloidosis drug, this time paying $125 million upfront to Neurimmune for a cut of the sales of its AstraZeneca-partnered med.Fierce Biotech · 5d ago↗ source
- As Maui recovers from devastating fires, a study offers vision for new rural health modelA study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.